U

UMediC Group Bhd
KLSE:UMC

Watchlist Manager
UMediC Group Bhd
KLSE:UMC
Watchlist
Price: 0.62 MYR 2.48% Market Closed
Market Cap: 231.8m MYR
Have any thoughts about
UMediC Group Bhd?
Write Note
Section:
 

Relative Value

The Relative Value of one UMC stock under the Base Case scenario is 0.99 MYR. Compared to the current market price of 0.62 MYR, UMediC Group Bhd is Undervalued by 37%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

UMC Relative Value
Base Case
0.99 MYR
Undervaluation 37%
Relative Value
Price
U
Worst Case
Base Case
Best Case

Valuation Multiples

4.2
P/S
P/S
Price to Sales
4.2
vs History
70
vs Industry
24
Median 3Y
4.8
Median 5Y
4.8
Industry
2.3
Forward
3.4
More Details
25.8
P/E
P/E
Price to Earnings
25.8
vs History
63
vs Industry
23
Median 3Y
25.7
Median 5Y
25.7
Industry
23
Forward
18.4
More Details
53.7
P/OCF
P/OCF
Price to OCF
53.7
vs History
70
vs Industry
1
Median 3Y
96.9
Median 5Y
96.9
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
14
Median 3Y
-39.1
Median 5Y
-39.1
Industry
20
More Details
3.2
P/B
P/B
Price to Book Value
3.2
vs History
90
vs Industry
22
Median 3Y
4.1
Median 5Y
4.1
Industry
2.2
More Details
3.9
EV/S
EV/S
Enterprise Value to Sales
3.9
vs History
70
vs Industry
23
Median 3Y
4.5
Median 5Y
4.5
Industry
2.4
Forward
3.2
More Details
9.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.3
vs History
70
vs Industry
17
Median 3Y
10.6
Median 5Y
10.6
Industry
5
More Details
13.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.8
vs History
73
vs Industry
23
Median 3Y
15.6
Median 5Y
15.6
Industry
12.9
Forward
11.2
More Details
16.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16.5
vs History
63
vs Industry
26
Median 3Y
17.5
Median 5Y
17.5
Industry
17.4
Forward
13
More Details
48.9
EV/OCF
EV/OCF
Enterprise Value to OCF
48.9
vs History
70
vs Industry
2
Median 3Y
90.2
Median 5Y
90.2
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
17
Median 3Y
-103
Median 5Y
-103
Industry
18.2
More Details
3.3
EV/IC
EV/IC
Enterprise Value to IC
3.3
vs History
90
vs Industry
19
Median 3Y
4.6
Median 5Y
4.6
Industry
1.9
More Details

Multiples Across Competitors

UMC Competitors Multiples
UMediC Group Bhd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
MY
UMediC Group Bhd
KLSE:UMC
224.3m MYR 4.2 25.8 13.8 16.5
US
Mckesson Corp
NYSE:MCK
75B USD 0.2 29.6 17.6 20.6
US
Cencora Inc
NYSE:COR
46.4B USD 0.2 30.7 11.3 15.5
US
Amerisourcebergen Corp
LSE:0HF3
46.2B USD 0.2 30.6 11.3 15.4
US
Cardinal Health Inc
NYSE:CAH
29.7B USD 0.1 23.5 10.6 14.1
US
Henry Schein Inc
NASDAQ:HSIC
8.9B USD 0.7 28.3 12.6 18.6
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
CN
Sinopharm Group Co Ltd
HKEX:1099
62.4B HKD 0.1 6.8 1.7 2.1
CN
Huadong Medicine Co Ltd
SZSE:000963
57.5B CNY 1.4 17.9 13.6 13.6
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
57.1B CNY 0.2 14.2 9.1 9.1
IT
Amplifon SpA
MIL:AMP
5.8B EUR 2.4 36.6 11.8 24.6

See Also

Summary
UMC intrinsic value, competitors valuation, and company profile.
DCF Valuation
UMC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
UMC stock valuation using valuation multiples.
Wall Street Estimates
UMC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
UMC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 216,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.